Participant Eligibility Screening: I reviewed patient medical histories, diagnoses, and prior autonomic dysreflexia episodes to determine whether individuals met the protocol’s requirements. This included verifying criteria such as chronic SCI above T6 and documented AD symptoms during bladder or bowel routines. My work ensured that only appropriate candidates were considered for enrollment, supporting both safety and data integrity.

Chart Review & Data Verification: I examined electronic medical records to confirm demographic information, injury level, comorbidities, and any exclusionary conditions. This step was essential because the protocol excludes individuals with conditions such as diabetes, chronic heart disease, or pacemaker dependence.

Collaboration With Clinical Staff:I communicated findings to the research team and assisted in preparing lists of qualified participants for upcoming urodynamic testing sessions. This helped streamline workflow and ensured that clinicians had accurate, up‑to‑date information.

Exposure to Clinical Research Operations: Through this project, I gained experience with IRB‑approved protocols, patient confidentiality standards, and the practical steps involved in preparing participants for a controlled clinical study.